PDF herunterladen
Dtsch Med Wochenschr 2013; 138(05): 218-222
DOI: 10.1055/s-0032-1332828
Prävention & Versorgungsforschung | Review article
Kardiologie, Versorgungsforschung
© Georg Thieme Verlag KG Stuttgart · New York

Die kathetergestützte Aortenklappenimplantation (TAVI) zur Behandlung der Aortenklappenstenose – Aspekte der Versorgungsforschung

Transcatheter aortic valve implantation (TAVI) for the treatment of aortic stenosis: aspects of health care research
M. Thoenes
1   Léman Research Institute, Oberägeri, Schweiz
2   Institut für klinische Pharmakologie, Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus
,
H. Treede
3   Universitäres Herzzentrum, Universitätsklinikum Hamburg-Eppendorf
,
O. Franzen
4   Abteilung für Kardiologie, Rigshospitalet, Copenhagen University Hospital, Dänemark
,
W. Kirch
2   Institut für klinische Pharmakologie, Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
22. Januar 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Schlüsselwörter

Herzklappenerkrankungen - Aortenstenose - kathetergestützte Aortenklappenimplantation - TAVI - Versorgungsforschung

Keywords

heart valve disease - aortic stenosis - transcatheter aortic valve implantation - TAVI - health care research
 

  • Literatur

  • 1 AQUA Institut. HCH-AORT-KATH – Aortenklappenchirurgie, isoliert (Kathetergestützt) – Bundesauswertung 2011. 2012
    PubMedGoogle Scholar
  • 2 Bosmans JM, Kefer J, De Bruyne B et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011; 12: 762-767
    CrossrefPubMedGoogle Scholar
  • 3 Clark MA, Arnold SV, Duhay FG et al. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Circ Cardiovasc Qual Outcomes 2012; 5: 697-704
    CrossrefPubMedGoogle Scholar
  • 4 Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-3008
    CrossrefPubMedGoogle Scholar
  • 5 Eveborn GW, Schirmer H, Heggelund G et al. The evolving epidemiology of valvular aortic stenosis. The Tromso Study. Heart 2012; Sep 2. [Epub ahead of print]
    PubMedGoogle Scholar
  • 6 Ferreira-Gonzalez I, Pinar-Sopena J, Ribera A et al. Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area. Eur J Prev Cardiol 2012;
    PubMedGoogle Scholar
  • 7 Funkat AK, Beckmann A, Lewandowski J et al. Cardiac surgery in Germany during 2011: A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2012; 60: 371-382
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 8 Gilard M, Eltchaninoff H, Iung B et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715
    CrossrefPubMedGoogle Scholar
  • 9 Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243
    CrossrefPubMedGoogle Scholar
  • 10 Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011; 8: 162-172
    CrossrefPubMedGoogle Scholar
  • 11 Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-1695
    CrossrefPubMedGoogle Scholar
  • 12 Makkar RR, Fontana GP, Jilaihawi H et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366: 1696-1704
    CrossrefPubMedGoogle Scholar
  • 13 Moat NE, Ludman P, de Belder MA et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011; 58: 2130-2138
    CrossrefPubMedGoogle Scholar
  • 14 Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-1011
    CrossrefPubMedGoogle Scholar
  • 15 Rosenhek R, Binder T, Porenta G et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611-617
    CrossrefPubMedGoogle Scholar
  • 16 Statista. Bevölkerung Deutschland nach Altersgruppen. http://de.statista.com/statistik/faktenbuch/338/a/laender/deutschland/bevoelkerung-in-deutschland/
    Google Scholar
  • 17 Ussia GP, Barbanti M, Petronio AS et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 2012; 33: 969-976
    CrossrefPubMedGoogle Scholar
  • 18 Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33: 2451-2496
    CrossrefPubMedGoogle Scholar
  • 19 Vahanian A. 30 day outcomes in a 20700 patient international clinical registry with a second generation balloon expandable transcatheter heart valve using multiple access techniques. Paris: EuroPCR; 2012
    Google Scholar
  • 20 Varadarajan P, Kapoor N, Bansal RC et al. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: Results from a cohort of 277 patients aged > or =80 years. Eur J Cardiothorac Surg 2006; 30: 722-727
    CrossrefPubMedGoogle Scholar
  • 21 Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763
    CrossrefPubMedGoogle Scholar